Pineapple makes first move in $100m Injective treasury play

Pineapple has executed its first open-market buy of 678,353 INJ tokens valued at $8.9 million. The purchase launches the company’s $100 million Injective treasury, which it said will be staked to generate yield and strengthen its onchain presence.

According to a press release dated Oct. 7, the Toronto-based fintech firm has officially activated its $100 million Digital Asset Treasury strategy, funded by a private placement last month.

The initial acquisition of 678,353 Injective (INJ) tokens is the first tranche in a series of planned market purchases, kicking off a corporate campaign with the goal of becoming the single largest holder and staker of INJ. Notably, the Pineapple team confirmed the entire position will be staked onchain immediately.

Pineapple to expand its Injective footprint beyond token accumulation

According to the release, Pineapple intends to deeply integrate Injective’s decentralized infrastructure directly into its core business lines. The company plans to leverage the blockchain for critical mortgage-finance functions, including data management, loan servicing, settlement, and the nascent field of real-world asset tokenization.

This suggests a future where elements of the home loan process could be managed onchain, an ambitious technical undertaking that goes far beyond simple token acquisition.

Pineapple’s pivot arrives during a period of notable institutional momentum for the Injective ecosystem. Just days prior to Pineapple’s announcement, asset managers Rex Shares and Osprey Funds formally filed with the SEC for a staked INJ exchange-traded fund.

This move, which places INJ alongside other digital-infrastructure assets in the ETF Opportunities Trust, signals a growing recognition of the token’s value proposition within traditional finance circles.

Simultaneously, Injective has been expanding its suite of sophisticated financial products. Earlier this month, the protocol launched onchain pre-IPO perpetual markets, allowing for leveraged trading of synthetic shares for major private companies like OpenAI.

These markets, which are fully onchain and decentralized, represent a direct effort to bridge traditional finance with DeFi, offering global access to a market segment historically reserved for large institutions. Injective’s push into real-world-asset derivatives has already seen substantial volume, with the protocol reporting over $1 billion in RWA perpetual-futures trading in recent weeks.